Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Garrón

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Reviews of Infectious Diseases|July 1, 1991
Cefazolin-induced encephalopathy in uremic patientsA Ortiz, N Martin-Llonch, M P Garrón, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1993
Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virusC Caramelo, A Ortiz, B Aguilera, et al.
Circulation Research|March 1, 1994
Mechanisms of the endothelial toxicity of cyclosporin A. Role of nitric oxide, cGMP, and Ca2+M J Gallego, A L García Villalón, A J López Farre, et al.
Nephron|January 1, 1992
Positive Elisa 2 is pathologically relevant in Elisa-1-negative patients on hemodialysisC Caramelo, V Carreño, E González Parra, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Reviews of Infectious Diseases|July 1, 1991
Cefazolin-induced encephalopathy in uremic patientsA Ortiz, N Martin-Llonch, M P Garrón, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1993
Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virusC Caramelo, A Ortiz, B Aguilera, et al.
Circulation Research|March 1, 1994
Mechanisms of the endothelial toxicity of cyclosporin A. Role of nitric oxide, cGMP, and Ca2+M J Gallego, A L García Villalón, A J López Farre, et al.
Nephron|January 1, 1992
Positive Elisa 2 is pathologically relevant in Elisa-1-negative patients on hemodialysisC Caramelo, V Carreño, E González Parra, et al.
Pageof 1